| Authors: |
Jain P; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ; Division of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD., Naqvi SAA; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ; Division of Internal Medicine, Mayo Clinic, Phoenix, AZ., Tripathi N; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ; Division of Internal Medicine, Creighton University, Phoenix, AZ., Oberoi JK; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ., Humayun MA; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ., Zakharia Y; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ., Orme JJ; Division of Hematology and Medical Oncology, Mayo Clinic, Rochester, MN., Kase A; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL., Childs DS; Division of Hematology and Medical Oncology, Mayo Clinic, Rochester, MN., Chen R; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL., Riaz IB; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ., Singh P; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ. Electronic address: Singh.Parminder@mayo.edu. |
